Maxell, Ltd. (TSE:6810) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

It's been a good week for Maxell, Ltd. (TSE:6810) shareholders, because the company has just released its latest first-quarter results, and the shares gained 2.5% to JP¥1,971. Revenues came in 4.0% below expectations, at JP¥30b. Statutory earnings per share were relatively better off, with a per-share profit of JP¥93.12 being roughly in line with analyst estimates. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, Maxell's seven analysts currently expect revenues in 2026 to be JP¥130.8b, approximately in line with the last 12 months. Per-share earnings are expected to leap 114% to JP¥172. Before this earnings report, the analysts had been forecasting revenues of JP¥131.0b and earnings per share (EPS) of JP¥170 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Maxell

The analysts reconfirmed their price target of JP¥2,200, showing that the business is executing well and in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Maxell at JP¥2,700 per share, while the most bearish prices it at JP¥1,800. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. One thing stands out from these estimates, which is that Maxell is forecast to grow faster in the future than it has in the past, with revenues expected to display 2.2% annualised growth until the end of 2026. If achieved, this would be a much better result than the 2.1% annual decline over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 6.2% per year. So although Maxell's revenue growth is expected to improve, it is still expected to grow slower than the industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at JP¥2,200, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Maxell going out to 2028, and you can see them free on our platform here..

Before you take the next step you should know about the 3 warning signs for Maxell that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.